Press Releases

Filters
October 11, 2018

Debiopharm International SA and the Paul Scherrer Institute announce a licensing agreement for the development of a novel targeted radiotherapeutic…

Read more
September 28, 2018

The Japanese Cancer Association and Debiopharm Group Announce Winners of the 2018 JCA-Mauvernay Award

Read more
August 22, 2018

Le Challenge Debiopharm-Inartis récompense ses cinq finalistes 2018

Read more
May 8, 2018

FDA Grants Fast Track designation to Debiopharm International’s Debio 1347 for the treatment of patients with unresectable or metastatic tumors…

Read more
April 5, 2018

Kaiku Health raises €4.4 million series A financing to accelerate its digital therapeutics pipeline led by Debiopharm and Tesi

Read more
March 22, 2018

Challenge Qualité de vie du patient 2018 : l’appel à projets est ouvert !

Read more
February 19, 2018

GenePOC launches its revogene™ instrument and GBS LB test in Canada

Read more
February 15, 2018

Debiopharm continues the fight against antibiotic resistance with investment in ABAC Therapeutics Inc.

Read more
February 7, 2018

Le groupe autrichien ams acquiert KeyLemon

Read more